SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-060152
Filing Date
2021-12-13
Accepted
2021-12-13 16:00:50
Documents
12
Period of Report
2021-12-13
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K onct-8k_20211213.htm   iXBRL 8-K 44370
  Complete submission text file 0001564590-21-060152.txt   175257

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA onct-20211213.xsd EX-101.SCH 5689
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE onct-20211213_lab.xml EX-101.LAB 19326
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE onct-20211213_pre.xml EX-101.PRE 11489
5 EXTRACTED XBRL INSTANCE DOCUMENT onct-8k_20211213_htm.xml XML 3564
Mailing Address 12230 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 12230 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 434-1113
Oncternal Therapeutics, Inc. (Filer) CIK: 0001260990 (see all company filings)

IRS No.: 621715807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50549 | Film No.: 211488052
SIC: 2834 Pharmaceutical Preparations